Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

lradvanyi_2

Merck appoints Laszlo Radvanyi as head of global immuno-oncology research

November 4, 2015 Research and Development Laszlo Radvanyi, Merck

Dr Laszlo Radvanyi has joined Merck as senior vice president and head of research in immuno-oncology.  The Merck Group says …
Appointment
GSK logo

GSK plots return to growth with launch of 20 new drugs by 2020

November 4, 2015 Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline

GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …
News
researchers examining test tube

Drugs later in development ‘winning the race to market’

November 4, 2015 Research and Development R&D, drug approval, drug development, market exclusivity

Nearly all later entrants to drug classes were in clinical testing or regulatory review before first-in-class approval, according to the …
News
Andrew Witty GSK

Pfizer approached GSK for takeover before Allergan

November 4, 2015 Research and Development, Sales and Marketing Allergan, GSK, Pfizer, financial results, product pipeline

Pfizer had a takeover approach rejected by fellow pharma giant GlaxoSmithKline, before turning its attentions to Allergan, it has emerged. …
News
BMS building

Bristol-Myers Squibb enters academic R&D tie-up

November 4, 2015 Research and Development BMS, Bristol-Myers Squibb, Cardioxy, John Hopkins, acquisition, immunooncology, job losses

Bristol-Myers Squibb and The Johns Hopkins University have entered into a collaboration agreement, as part of the pharma firm’s rare …
News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015 Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …
News
Prof Paul Workman

Putting off-patent drugs back to work

November 4, 2015 Research and Development, Sales and Marketing Off-Patent Drugs Bill, Professor Paul Workman, The ICR, The ICR London, drug repurposing, patents

Six clinicians here at The Institute of Cancer Research, London, have joined colleagues from across the UK in writing to …
Feature
GSK building

GSK and Merck to study immunotherapy combo in solid tumours

November 3, 2015 Research and Development GSK, Merck, immunooncology, immunotherapy, keytruda, phase I

GSK and Merck will start a Phase I clinical trial in humans to evaluate GSK’s investigational cancer drugs with the …
News
paul_oliver_cfo_biocity

Pharma R&D hub BioCity appoints new CFO

November 3, 2015 Manufacturing and Production, Research and Development, Sales and Marketing BioCity, Paul Oliver

BioCity, the UK bioscience incubator, has appointed Paul Oliver as chief financial officer as it prepares to grow across its …
Appointment
R&D

Sanofi and BioNTech in cancer immunotherapy partnership

November 3, 2015 Manufacturing and Production, Research and Development BioNTech, Cancer, Sanofi, immunotherapy

Sanofi and BioNTech have agreed a new multi-year exclusive collaboration and license agreement, to discover and develop up to five …
News
Shire

Shire to acquire Dyax in $5.9 billion deal

November 2, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Dyax, M&A, MA, R&D, Shire, hereditary angioedema, rare disease

Shire has struck a deal to acquire the biotech firm Dyax for $5.9 billion, in order to acquire exclusive rights …
News
neil_brewis_photo

Biopharma firm F-star appoints Dr Neil Brewis as CSO

November 2, 2015 Manufacturing and Production, Research and Development F-star, Neil Brewis

F-star, a biopharma company focused on immuno-oncology, has hired Dr Neil Brewis as chief scientific officer. Dr Brewis is a former vice …
Appointment
EU flag

European Commission funds €23m project to develop HIV vaccine

November 2, 2015 Research and Development, Sales and Marketing BioNTech, European Commission, HIV, R&D, horizon 2020

The European Commission has kicked-off a new €23 million research program to bring together researchers to work on a potential …
News
eylea

Bayer, Regeneron’s Eylea gets additional EU indication

November 2, 2015 Research and Development, Sales and Marketing Bayer, Eylea, Regeneron

The European Commission has granted a fifth indication to Bayer and Regeneron’s eye drug Eylea (aflibercept injection), which is now …
News
Merck R&D

Merck and Selvita form oncology partnership

November 2, 2015 Research and Development, Sales and Marketing Merck, Selvita, collaboration, oncology

Merck has entered a three-year agreement with Selvita to validate new therapeutic concepts in the field of oncology. The aim …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025